Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control study

Authors: Noémie Boillat-Blanco, Pascal Bovet, Kaushik L. Ramaiya, Maliwasa Mganga, Lilian T. Minja, Lanja Saleh, Medea Imboden, Christian Schindler, Sebastien Gagneux, Claudia Daubenberger, Klaus Reither, Nicole Probst-Hensch

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Vitamin D level is inversely associated with tuberculosis (TB) and diabetes (DM). Vitamin D could be a mediator in the association between TB and DM. We examined the associations between vitamin D, TB and DM.

Methods

Consecutive adults with TB and sex- and age-matched volunteers were included in a case-control study in Dar es Salaam, Tanzania. Glycemia and total vitamin D (25(OH)D) were measured at enrolment and after TB treatment in cases. The association between low 25(OH)D (<75 nmol/l) and TB was evaluated by logistic regression adjusted for age, sex, body mass index, socioeconomic status, sunshine hours, HIV and an interaction between low 25(OH)D and hyperglycemia.

Results

The prevalence of low 25(OH)D was similar in TB patients and controls (25.8 % versus 31.0 %; p = 0.22). In the subgroup of patients with persistent hyperglycemia (i.e. likely true diabetic patients), the proportion of patients with low 25(OH)D tended to be greater in TB patients (50 % versus 29.7 %; p = 0.20). The effect modification by persistent hyperglycemia persisted in the multivariate analysis (pinteraction = 0.01).

Conclusions

Low 25(OH)D may increase TB risk in patients with underlying DM. Trials should examine if this association is causal and whether adjunct vitamin D therapy is beneficial in this population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.CrossRefPubMedPubMedCentral Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.CrossRefPubMedPubMedCentral
2.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed
3.
go back to reference Martineau AR. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc. 2012;71(1):84–9.CrossRefPubMed Martineau AR. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc. 2012;71(1):84–9.CrossRefPubMed
4.
go back to reference Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261–70.CrossRefPubMed Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261–70.CrossRefPubMed
5.
go back to reference Xuan Y, Zhao HY, Liu JM. Vitamin D and type 2 diabetes mellitus (D2). J Diabetes. 2013;5(3):261–7.CrossRefPubMed Xuan Y, Zhao HY, Liu JM. Vitamin D and type 2 diabetes mellitus (D2). J Diabetes. 2013;5(3):261–7.CrossRefPubMed
7.
go back to reference Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991–2000.CrossRefPubMedPubMedCentral Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991–2000.CrossRefPubMedPubMedCentral
8.
go back to reference Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.CrossRefPubMedPubMedCentral Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.CrossRefPubMedPubMedCentral
9.
go back to reference Hawn TR, Shah JA, Kalman D. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev. 2015;264(1):344–62.CrossRefPubMedPubMedCentral Hawn TR, Shah JA, Kalman D. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev. 2015;264(1):344–62.CrossRefPubMedPubMedCentral
10.
go back to reference Handel AE, Ramagopalan SV. Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis. 2010;10(9):596.CrossRefPubMed Handel AE, Ramagopalan SV. Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis. 2010;10(9):596.CrossRefPubMed
11.
go back to reference Chaudhary S, Thukral A, Tiwari S, Pratyush DD, Singh SK. Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis. Indian J Endocrinol Metab. 2013;17 Suppl 3:S670–3.CrossRefPubMedPubMedCentral Chaudhary S, Thukral A, Tiwari S, Pratyush DD, Singh SK. Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis. Indian J Endocrinol Metab. 2013;17 Suppl 3:S670–3.CrossRefPubMedPubMedCentral
12.
go back to reference Zhan Y, Jiang L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med. 2015;9(1):11–6.PubMed Zhan Y, Jiang L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med. 2015;9(1):11–6.PubMed
13.
go back to reference Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A. 2012;109(38):15449–54.CrossRefPubMedPubMedCentral Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A. 2012;109(38):15449–54.CrossRefPubMedPubMedCentral
14.
go back to reference Kota SK, Jammula S, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr. 2011;5(2):85–9.CrossRefPubMed Kota SK, Jammula S, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr. 2011;5(2):85–9.CrossRefPubMed
15.
go back to reference Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377(9761):242–50.CrossRefPubMedPubMedCentral Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377(9761):242–50.CrossRefPubMedPubMedCentral
16.
go back to reference Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38(1):3–5.PubMed Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38(1):3–5.PubMed
17.
go back to reference Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843–50.CrossRefPubMed Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843–50.CrossRefPubMed
18.
go back to reference Daley P, Jagannathan V, John KR, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(5):528–34.CrossRefPubMed Daley P, Jagannathan V, John KR, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(5):528–34.CrossRefPubMed
19.
go back to reference Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis. 2016;213(7):1163–72.CrossRefPubMed Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis. 2016;213(7):1163–72.CrossRefPubMed
20.
go back to reference URTanzania. United Republic of Tanzania. National Tuberculosis and Leprosy Programme and Ministry of Health and Social Welfare. Manual for the Management of Tuberculosis and Leprosy. 2013; 6th Ed. URTanzania. United Republic of Tanzania. National Tuberculosis and Leprosy Programme and Ministry of Health and Social Welfare. Manual for the Management of Tuberculosis and Leprosy. 2013; 6th Ed.
22.
go back to reference WHO. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization; 2010. WHO. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization; 2010.
23.
go back to reference Hartung CA, Brunette W, Lerer A, Tseng C, Borriello G. Open Data Kit: building information services for developing regions. London: International Conference on Information and Communication Technologies for Development (ICTD); 2010.CrossRef Hartung CA, Brunette W, Lerer A, Tseng C, Borriello G. Open Data Kit: building information services for developing regions. London: International Conference on Information and Communication Technologies for Development (ICTD); 2010.CrossRef
24.
go back to reference Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRefPubMed Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRefPubMed
25.
go back to reference Essack Y, Hoffman M, Rensburg M, Van Wyk J, Meyer CS, Erasmus R. A comparison of five glucometers in South Africa. JEMDSA. 2009;14(2):102–5. Essack Y, Hoffman M, Rensburg M, Van Wyk J, Meyer CS, Erasmus R. A comparison of five glucometers in South Africa. JEMDSA. 2009;14(2):102–5.
26.
go back to reference WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. 2006. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. 2006.
27.
go back to reference Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211–23.CrossRefPubMed Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211–23.CrossRefPubMed
28.
29.
go back to reference Friis H, Range N, Changalucha J, et al. Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania. PLoS One. 2013;8(12):e81142.CrossRefPubMedPubMedCentral Friis H, Range N, Changalucha J, et al. Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania. PLoS One. 2013;8(12):e81142.CrossRefPubMedPubMedCentral
30.
go back to reference Koo HK, Lee JS, Jeong YJ, et al. Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 2012;17(5):808–13.CrossRefPubMed Koo HK, Lee JS, Jeong YJ, et al. Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 2012;17(5):808–13.CrossRefPubMed
31.
go back to reference Sloan DJ, Mwandumba HC, Kamdolozi M, et al. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2015;19(8):904–11.CrossRefPubMedPubMedCentral Sloan DJ, Mwandumba HC, Kamdolozi M, et al. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2015;19(8):904–11.CrossRefPubMedPubMedCentral
32.
go back to reference Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis. 2013;207(3):378–85.CrossRefPubMed Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis. 2013;207(3):378–85.CrossRefPubMed
33.
go back to reference Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A. 2011;108(47):19013–7.CrossRefPubMedPubMedCentral Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A. 2011;108(47):19013–7.CrossRefPubMedPubMedCentral
34.
go back to reference Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–9.CrossRefPubMed Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–9.CrossRefPubMed
35.
go back to reference Durazo-Arvizu RA, Camacho P, Bovet P, et al. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr. 2014;100(3):908–14.CrossRefPubMedPubMedCentral Durazo-Arvizu RA, Camacho P, Bovet P, et al. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr. 2014;100(3):908–14.CrossRefPubMedPubMedCentral
36.
go back to reference Pareek M, Innes J, Sridhar S, et al. Vitamin D deficiency and TB disease phenotype. Thorax. 2015;70(12):1171–80.CrossRefPubMed Pareek M, Innes J, Sridhar S, et al. Vitamin D deficiency and TB disease phenotype. Thorax. 2015;70(12):1171–80.CrossRefPubMed
37.
go back to reference Davies PD, Martineau AR. Vitamin D and tuberculosis: more effective in prevention than treatment? Int J Tuberc Lung Dis. 2015;19(8):876–7.CrossRefPubMed Davies PD, Martineau AR. Vitamin D and tuberculosis: more effective in prevention than treatment? Int J Tuberc Lung Dis. 2015;19(8):876–7.CrossRefPubMed
Metadata
Title
Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control study
Authors
Noémie Boillat-Blanco
Pascal Bovet
Kaushik L. Ramaiya
Maliwasa Mganga
Lilian T. Minja
Lanja Saleh
Medea Imboden
Christian Schindler
Sebastien Gagneux
Claudia Daubenberger
Klaus Reither
Nicole Probst-Hensch
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1960-x

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue